Cardiologist and JAMA Deputy Editor Greg Curfman, MD, discusses the many changes in the new AHA/ACC/HRS atrial fibrillation guidelines with University of Chicago cardiologists Gaurav Upadhyay, MD, and Francis Alenghat, MD, PhD. Major changes include recommendations for the use of various agents for anticoagulation, catheter ablation, and left atrial appendage occlusion. Read the article: Management of Patients With Atrial Fibrillation Index of content: 2:19 Summary of the new ACC/AHA Atrial Fibrillation Guideline 8:04 Cost and efficacy of NOACs used to treat atrial fibrillation 11:42 Preference for specific NOACs 14:00 Rate vs rhythm control 20:00 How catheter ablation is performed 26:20 Anticoagulation requirements following ablation 31:23 How to achieve rate control 32:25 Left atrial appendage occlusion devices 36:29 New lifestyle recommendation 37:44 More about rate vs rhythm control

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related